切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2019, Vol. 15 ›› Issue (01) : 46 -50. doi: 10.3877/cma.j.issn.1673-5250.2019.01.008

所属专题: 文献

论著

新生儿结节性硬化症并文献复习
张勇1, 蔡保欢1,()   
  1. 1. 华中科技大学同济医学院附属同济医院儿科,武汉 430030
  • 收稿日期:2018-06-06 修回日期:2019-01-02 出版日期:2019-02-01
  • 通信作者: 蔡保欢

Neonatal tuberous sclerosis complex: a case report and literatures review

Yong Zhang1, Baohuan Cai1,()   

  1. 1. Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, Hubei Province, China
  • Received:2018-06-06 Revised:2019-01-02 Published:2019-02-01
  • Corresponding author: Baohuan Cai
  • About author:
    Corresponding author: Cai Baohuan, Email:
  • Supported by:
    National Natural Science Foundation of China(81601328)
引用本文:

张勇, 蔡保欢. 新生儿结节性硬化症并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(01): 46-50.

Yong Zhang, Baohuan Cai. Neonatal tuberous sclerosis complex: a case report and literatures review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2019, 15(01): 46-50.

目的

总结新生儿结节性硬化症(TSC)的临床特点。

方法

选择2017年12月13日,以高危儿,新生儿结节性硬化症待查,收入华中科技大学同济医学院附属同济医院,并确诊的1例新生儿TSC为研究对象。对患儿的临床病例资料进行回顾性分析,总结其临床特点。TSC文献复习的文献检索策略为:以"结节性硬化症""新生儿硬化病""心脏横纹肌瘤""tuberous sclerosis""neonate""neonatal cardiac tumor"为关键词,对万方数据知识服务平台、中国知网数据库及PubMed文献数据库建库至2017年4月,收录的关于TSC的文献进行检索,并总结其临床特点。本研究符合2013年修订的《世界医学协会赫尔辛基宣言》要求。

结果

①患儿,女性,生后30 min,入院诊断为高危儿,新生儿结节性硬化症待查。患儿在母亲孕龄为37孕周时,经胎儿心脏彩色多普勒超声检查,发现胎儿"心脏横纹肌瘤";出生后无特异性临床症状及体征,实验室检查结果基本正常,头颅MRI检查结果提示"室管膜下结节",临床诊断为TSC。患儿入院后接受营养、支持治疗5 d,病情稳定,自动出院。电话随访至患儿生后5个月时,未出现抽搐及皮肤损害。②TSC相关文献检索结果显示,新生儿TSC最常见临床表现为皮肤改变,其次为心脏、中枢神经系统病变;少数接受基因检测的患儿可见TSC2基因复合杂合突变,但是亦有部分符合TSC临床诊断的TSC患儿,其基因检测结果为阴性。

结论

对新生儿期无明显特征性临床表现的患儿,新生儿医师应加强对TSC的识别与筛查,避免漏诊与误诊。

Objective

To summarize the clinical characteristics of neonatal tuberous sclerosis complex (TSC).

Methods

On December 13, 2017, due to high-risk infants, neonatal tuberous sclerosis complex yet to be investigated, a neonatal TSC was admitted and made a definite diagnosis in Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology was chosen as research subject. Retrospective analysis was made on the clinical case data of the infant and the clinical characteristics were summarized. Setting up the retrieval strategy for TSC literatures review: with the key words of "tuberous sclerosis" "neonatal sclerosis" and "cardiac rhabdomyoma" in Chinese, "tuberous sclerosis" "neonate" and"neonatal cardiac tumor" in English, the literatures on TSC were collected from Wanfang Data Knowledge Service Platform, China National Knowledge Infrastructure database and PubMed literatures database from construction to April 2017, and the clinical characteristics of TSC from these literatures were summarized. This study was in line with World Medical Association Declaration of Helsinki revised in 2013.

Results

①This patient was a girl with age of 30 min after birth when hospitalized, the admission diagnosis was high-risk infant, neonatal tuberous sclerosis complex yet to be investigated. Fetal heart color Doppler echocardiography at 37 gestational age showed "cardiac rhabdomyoma". There were no specific clinical symptoms or signs after birth, and the results of laboratory examination were basically normal. The results of cranial MRI showed "subependymal nodules". The neonatal was diagnosed as TSC by clinical manifestations. After admission, the neonatal was given nutrition and supportive treatments for 5 days, and the pathogenetic condition was stable and she was discharged by her parents′ request. There was no convulsions or skin lesions during the telephone follow-up until 5 months after birth. ②The results of literatures searched about TSC showed that the most common clinical manifestations of neonatal TSC were skin lesions, followed by cardiac and central nervous system lesions, and a few of these infants who underwent genetic examination had TSC2 gene compound heterozygous mutation, also part of TSC patients who accorded with clinical diagnosis of TSC got negative genetic examination results.

Conclusions

Neonatal physicians should strengthen the identification and screening of TSC for those neonates without typical clinical manifestations to avoid missed diagnosis and misdiagnosis.

图1 1例结节性硬化症新生儿生后48 h的头颅MRI影像图[图1A:矢状位短T1高信号,显示额顶叶及室管膜下结节样改变(白色箭头所示);图1B:轴位短T1高信号,显示额顶叶结节样改变(白色箭头所示);图1C:轴位短T1高信号,显示室管膜下结节样改变(白色箭头所示);图1D:轴位短T2低信号,显示室管膜下结节样改变(白色箭头所示)]
[1]
Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference[J]. Pediatr Neurol, 2013, 49(4): 255-265.
[2]
Au KS, Williams AT, Roach ES, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States[J]. Genet Med, 2007, 9(2): 88-100.
[3]
Lamb RF, Roy C, Diefenbach TJ, et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho[J]. Nature Cell Biology, 2000, 2(5): 281-287.
[4]
Wienecke R, König A, Declue JE. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity[J]. J Biol Chem, 1995, 270(27): 16409-16414.
[5]
Tee AR, Fingar DC, Manning BD, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling[J]. Proc Natl Acad Sci USA, 2002, 99(21): 13571-13576.
[6]
Beaumont TL, Limbrick DD, Smyth MD. Advances in the management of subependymal giant cell astrocytoma[J]. Childs Nerv Syst, 2012, 28(7): 963-968.
[7]
Kotulska K, Borkowska J, Roszkowski M, et al. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients[J]. Pediatr Neurol, 2014, 50(4): 307-312.
[8]
Pajak L, Jin F, Xiao GH, et al. Sustained cardiomyocyte DNA synthesis in whole embryo cultures lacking the TSC2 gene product[J]. Am J Physiol, 1997, 273(3 Pt 2): H1619-H1627.
[9]
Au KS, Rodriguez JA, Finch JL, et al. Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients[J]. Am J Hum Genet, 1998, 62(2): 286-294.
[10]
Niida Y, Lawrence-Smith N, Banwell A, et al. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis[J]. Hum Mutat, 1999, 14(5): 412-422.
[11]
Hodges AK, Li S, Maynard J, et al. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin[J]. Hum Mol Genet, 2001, 10(25): 2899-2905.
[12]
Hallett L, Foster T, Liu Z, et al. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review[J]. Curr Med Res Opin, 2011, 27(8): 1571-1583.
[13]
Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex[J]. N Engl J Med, 2006, 355(13): 1345-1356.
[14]
Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis[J]. Lancet, 2008, 372(9639): 657-668.
[15]
Northrup H, Wheless JW, Bertin TK, et al. Variability of expression in tuberous sclerosis[J]. J Med Genet, 1993, 30(1): 41-43.
[16]
Yates JR, Maclean C, Higgins JN, et al. The tuberous sclerosis 2 000 study: presentation, initial assessments and implications for diagnosis and management[J]. Arch Dis Child, 2011, 96(11): 1020-1025.
[17]
Goh S, Butler W, Thiele EA. Subependymal giant cell tumors in tuberous sclerosis complex[J]. Neurology, 2004, 63(8): 1457-1461.
[18]
宋治海.结节性硬化症1例[J/CD].中华妇幼临床医学杂志(电子版),2014,10(3): 397-398.
[19]
Hinton RB, Prakash A, Romp RL, et al. Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group[J]. J Am Heart Assoc, 2014, 3(6): e001493.
[20]
Roach ES, Dimario FJ, Kandt RS, et al. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association[J]. J Child Neurol, 1999, 14(6): 401-407.
[1] 庞嘉越成, 巨淑慧, 马冀青, 李恒宇, 盛湲. 乳腺癌易感基因突变人群接受降低乳腺癌风险手术的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 179-183.
[2] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[3] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[4] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[5] 杨莹, 刘艳, 王央丹. 新生儿结节性硬化症相关性癫痫1例并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 464-472.
[6] 阚路兰, 田茂强, 唐一蜜. 以腹痛为首发症状的轻型Gitelman综合征患儿1例及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 473-479.
[7] 赵金琦, 杨楠, 宫丽霏, 唐玥, 李璐璐, 杨海河, 孔元原. 2011—2020年北京市小于胎龄儿出生状况分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 278-286.
[8] 张小曼, 马筱秋, 许正锯, 张纯瑜, 何彩婷. 乙型肝炎病毒逆转录酶区耐药突变对血清乙型肝炎病毒表面抗原水平的影响[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 324-332.
[9] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[10] 杨晓健, 张炎, 冯嘉荣, 刘卓杰, 张浩. 先天性输精管缺如合并肾脏畸形三例CFTR基因突变检测并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 110-113.
[11] 苗田田, 拉周措毛, 侯枚珠. 肺淋巴管平滑肌瘤5例报道及文献复习[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 340-345.
[12] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[13] 刘操林, 谢卡飞, 吴思平. 脾错构瘤动脉栓塞治疗一例及文献复习[J]. 中华介入放射学电子杂志, 2023, 11(02): 188-192.
[14] 强光峰, 孟兰兰, 赵静, 牛峰海, 任雪云. 肺部超声评分对呼吸困难新生儿使用有创机械通气的预测价值[J]. 中华诊断学电子杂志, 2023, 11(02): 104-108.
[15] 王倩, 王永萍, 李新培, 杨成艳, 许慧, 孙凤娟, 刘亚平. 伴基因突变的低钾血症诊断学特征分析[J]. 中华诊断学电子杂志, 2023, 11(02): 115-119.
阅读次数
全文


摘要